conflict of interest in the drug supply chain; Reach out to manufacturers of active pharmaceutical ingredients

The head of the Syndicate of Pharmaceutical Raw Materials, Chemicals and Pharmaceutical Packaging criticized what he called "the lack of consultation with the Syndicate in currency decisions and the change of product groups in the field of active pharmaceutical ingredients by the Food and Drug Organization", warned about the future of this industry and pointed out that Iran is a global power in this field, and called for a review of support policies to maintain the technological status of the country.